Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results tags : Positive save search
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
rinvoq positive cell results study
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CERE | News | $42.14 1.3% 1.33% 1.3M
|
Finance
|
| O: 0.78%
H: 0.0%
C: 0.0%
disease positive for topline parkinson’s trial therapeutics results living
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
ITCI | News 0 d | $72.0 -6.12% -6.5% 4.7M
|
Health Technology
|
| O: 14.75%
H: 12.75%
C: 6.04%
positive topline therapy results study
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
ONVO | $1.15 2.68% 6.28% 580K
|
Health Technology
|
| O: 64.34%
H: 4.82%
C: -18.67%
fxr314 metabolic liver positive for results
Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
VIRX | $0.8971 -4.18% -4.36% 79K
|
Manufacturing
|
| O: -12.71%
H: 0.97%
C: -24.27%
t-cell positive topline trial therapeutics results
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Published: 2024-04-11 (Crawled : 11:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% -0.31% 5.1M
|
Finance
|
| O: -0.74%
H: 0.09%
C: -5.32%
LPCN | $5.44 2.26% 2.74% 21K
|
Health Technology
|
| O: 6.78%
H: 13.49%
C: 1.75%
obesity positive results
Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
ALKS | $23.78 -0.96% -0.97% 1.8M
|
Health Technology
|
| O: 4.48%
H: 0.82%
C: -2.05%
narcolepsy positive topline results study
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
PFE A | $25.39 -0.12% 0.24% 31M
|
Health Technology
|
| O: 0.73%
H: 2.49%
C: 0.11%
abrysvo disease positive risk for rsv results study
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study
Published: 2024-04-08 (Crawled : 20:00) - globenewswire.com
SWAV | $327.52 0.01% -0.02% 1.2M
|
Health Technology
|
| O: 0.05%
H: 0.54%
C: 0.49%
positive results study
Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Published: 2024-04-08 (Crawled : 11:00) - biospace.com/
OCS | $11.78 -1.01% -0.76% 57K
|
n/a
|
| O: 0.36%
H: 0.18%
C: -2.76%
ocs-01 positive treatment for meeting trial results
Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome
Published: 2024-04-07 (Crawled : 16:20) - prnewswire.com
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
| Email alert
Add to watchlist
positive for results study
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
BIOR | $0.6 -6.56% -7.02% 520K
|
Health Care and Social Assistan...
|
| O: 1.34%
H: 0.0%
C: -4.21%
bt-600 positive trial therapeutics results platform
CYduct Diagnostics Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
CYDX | $0.41 -14.15% 290
|
n/a
| Email alert
Add to watchlist
breast biomarker positive cancer diagnostics results study
Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
PTPI | $0.6979 1.15% 0.0% 230K
|
| Email alert
Add to watchlist
positive pharmaceuticals results study
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
ROIV | $10.37 -0.67% -0.68% 3.4M
|
Manufacturing
|
| O: 4.79%
H: 3.02%
C: -0.09%
pharma million authorization positive repurchase results study
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
VTGN | $4.69 0.43% 0.43% 200K
|
Health Technology
|
| O: -2.27%
H: 0.0%
C: 0.0%
positive treatment results study
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
Published: 2024-03-28 (Crawled : 12:30) - globenewswire.com
NXL | $1.5 13.64% 12.0% 320K
|
|
| O: 8.99%
H: 0.0%
C: 0.0%
device positive technology results study
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
BWAY | $4.79 -5.15% -5.21% 80K
|
Health Technology
|
| O: -0.19%
H: 3.15%
C: 0.95%
positive depression results
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-27 (Crawled : 11:00) - globenewswire.com
ALT | $6.89 -2.13% -2.03% 2.7M
|
Commercial Services
|
| O: 7.63%
H: 3.33%
C: -4.51%
year positive financial results
atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
Published: 2024-03-27 (Crawled : 11:00) - globenewswire.com
ATAI | $1.91 -3.54% -3.66% 1M
|
Manufacturing
|
| O: 4.05%
H: 1.11%
C: -0.56%
bpl-003 label life positive depression treatment sciences results study
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.